# Jasper Therapeutics, Inc.: insider transactions

JSPR · Nasdaq · CIK 1788028 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/jspr.md) · [Financials](/companies/jspr/financials.md) · [Filings](/companies/jspr/filings.md) · [Insiders](/companies/jspr/insiders.md)

## All transactions: 2

Non-derivative transactions reported on Forms 4, newest first. Codes P (purchase) and S (sale) are open-market trades. Reported price is as stated on the form, not a market price. Filter with ?type= `open-market`, `purchase`, `sale`.

| Date | Insider | Role | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | --- | ---: | ---: | ---: | --- |
| 2024-02-08 | [Carlyle Group Inc.](/insiders/1527166.md) | Former 10% Owner | Purchase (P) | 190,000 | $12.95 | $2.5m | [Form 4](/filings/0000950170-24-014017.md) |
| 2023-01-27 | [Carlyle Group Inc.](/insiders/1527166.md) | 10% owner | Purchase (P) | 3,133,333 | $1.50 | $4.7m | [Form 4](/filings/0000899243-23-003059.md) |

Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.